Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Why Is Merck & Company, Inc. (NYSE:MRK) Stock Trading Near A 52-Week High Today?

Merck & Company, Inc. (NYSE:MRK) rallied after the company and Moderna jointly reported on August 19, 2026 that the Phase 3 INTerpath-001 trial met its primary endpoint of recurrence-free survival and key secondary endpoint of distant metastasis-free survival. The study combined intismeran autogene, Moderna's …

Nitish Kishor | 20 August 2026

This Nasdaq Biotech Stock Just Hit A New 52-Week High After A Landmark Cancer Vaccine Trial And A New FDA Approval

Moderna, Inc. (NASDAQ:MRNA) shares surged after the company and Merck jointly announced on August 19, 2026 that the Phase 3 INTerpath-001 trial met its primary endpoint of recurrence-free survival and its key secondary endpoint of distant metastasis-free survival. The trial enrolled 1,137 patients with …

Nitish Kishor | 20 August 2026

Why Is Vaxcyte, Inc. (NASDAQ:PCVX) Stock Trading Near A 52-Week High Today?

Vaxcyte, Inc. (NASDAQ:PCVX), a clinical-stage vaccine developer, rose roughly 5.87% on August 20, 2026, moving to within about 2.6% of its 52-week high. The specific move does not appear to be tied to a distinct same-day Vaxcyte press release; rather, it coincides with a …

Nitish Kishor | 20 August 2026

This Nasdaq Bioprocessing Stock Just Hit A New 52-Week High After Moderna and Merck's Cancer Vaccine Win

Repligen Corporation (NASDAQ:RGEN) jumped roughly 6% on August 19-20, 2026, after Moderna and Merck reported that their Phase 3 INTerpath-001 trial of the personalized mRNA melanoma vaccine intismeran autogene, combined with Keytruda, met its primary endpoint of recurrence-free survival in patients with resected stage …

Nitish Kishor | 20 August 2026

This Nasdaq Bladder-Cancer Biotech Stock Just Hit A New 52-Week High After Phase 3 Data Win

CG Oncology, Inc. (NASDAQ:CGON) rose about 5.75% on August 20, 2026, pushing shares to essentially a fresh 52-week and all-time high near $80.68. The move builds on the July 27, 2026 publication of Phase 3 BOND-003 Cohort C results in The Lancet Oncology, evaluating …

Nitish Kishor | 20 August 2026

This NYSE Homebuilder Stock Is Rebounding Off 52-Week Lows After A Treasury-Driven Rate Relief Rally

Lennar Corporation (NYSE:LEN) shares rose about 3.6% to $87.30 on Thursday, August 20, 2026, part of a broader rally in homebuilder stocks. The gain followed the U.S. Treasury Department's August 19 announcement that it would roughly double its buybacks of long-dated government debt, which …

Nitish Kishor | 20 August 2026

Why Is Somnigroup International Inc. (NYSE:SGI) Stock Bouncing Near A 52-Week Low Today

Somnigroup International Inc. (NYSE:SGI), the bedding and mattress company formerly known as Tempur Sealy, saw its shares rise about 3.3% to $66.02 on Thursday, August 20, 2026. The move tracks a broader market rebound after the Treasury Department's August 19 announcement that it would …

Nitish Kishor | 20 August 2026

Why Is Wyndham Hotels & Resorts, Inc. (NYSE:WH) Stock Bouncing Near A 52-Week Low Today

Wyndham Hotels & Resorts, Inc. (NYSE:WH) shares climbed about 3.4% to $75.85 on Thursday, August 20, 2026, part of a wider bounce in travel, hospitality and franchise-model stocks. The move follows the U.S. Treasury Department's August 19 announcement that it would roughly double its …

Nitish Kishor | 20 August 2026

This NYSE Sports-Betting Stock Is Rebounding Off 52-Week Lows After A Brutal Post-Earnings Selloff

Flutter Entertainment plc (NYSE:FLUT), the parent of FanDuel and Paddy Power, rose about 6.75% to $99.16 as investors bought into shares that had been pounded for weeks. The stock had fallen more than 65% over the trailing year and remained within roughly 10.5% of …

Nitish Kishor | 20 August 2026

ATRenew (NYSE:RERE) Stock Falls 9% Pre-Market Despite Earnings Beat

ATRenew (NYSE:RERE) shares are down 8.50% in pre-market trading on August 20, giving back Wednesday's gain, as investors focus on soft forward guidance despite the company beating second-quarter 2026 expectations. Second-quarter net revenue rose 32.4% year-over-year to RMB 6.61 billion, with adjusted net income …

Nitish Kishor | 20 August 2026
Support

Hi! How can we help you today?

Loading…